Thursday, July 15, 2021

US FDA News: Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication

This Safety Communication describes the risk of false results, particularly false negative results, with the Curative SARS-Cov-2 test. Recommendations for patients, caregivers and health care professionals are provided.
Read more: Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication